You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 352 Updated clinical data from the squamous cell carcinoma of the head and neck (SCCHN) expansion cohort of an ongoing Ph1/1b Study of eganelisib (formerly IPI-549) in combination with nivolumab

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials in progress
352 Updated clinical data from the squamous cell carcinoma of the head and neck (SCCHN) expansion cohort of an ongoing Ph1/1b Study of eganelisib (formerly IPI-549) in combination with nivolumab

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020187014
Dec 20202604
Jan 20212707
Feb 20213309
Mar 20213007
Apr 20212208
May 202113022
Jun 2021006
Jul 2021007
Aug 2021005
Sep 2021009
Oct 202128021
Nov 202124020
Dec 202152012
Jan 20222602
Feb 20222608
Mar 20223006
Apr 20224805
May 20222201
Jun 20222002
Jul 20223104
Aug 202230011
Sep 20222603
Oct 202224012
Nov 202240012
Dec 20224008
Jan 20237408
Feb 20233609
Mar 20236605
Apr 202336012
May 20232204
Jun 20232407
Jul 20232806
Aug 20232801
Sep 20231803
Oct 20232204
Nov 20232403
Dec 20234402
Jan 2024600
Feb 20241800
Mar 20241602
Apr 202424010
May 20243000
Jun 20243201
Jul 20243002
Aug 20241400
Sep 20242205
Oct 2024604
Nov 20241602
Dec 20241205
Jan 20251409
Feb 2025403
Mar 20250011
Apr 20250011
May 2025002
Jun 2025004
Total14710360